Nine Deals Announced In August Worth $21.0 Billion The Biotech industry posted strong results in the M&A market during August. Nine deals were announced worth a combined total of $20.989 billion. The top three deals involved purchases of biotech concerns by large...
Pays $390.0 Million For Behavioral Services Provider Canadian private equity firm Onex Corp. (TSX: OCX) made a bid in mid-August to acquire the remainder of ResCare (NASDAQ: RSCR). In the second largest Behavioral Health Care deal of the year, behind Universal Health...
Sector Posts Hot M&A Activity This Summer Since the passage of health care reform in mid-March, merger and acquisition activity in the Hospital sector has become robust. Prior to passage, 2010 posted only five deals involving five single hospitals for a combined...
Opens Negotiations With $18.3 Billion Bid In what appears to be the industry’s worst-kept secret, Sanofi-Aventis (NYSE: SNY) has approached biotech giant Genzyme Corp. (NASDAQ: GENZ) with a takeover offer. Why it would do so, however, is no secret. Several of Sanofi’s...
A Total Of 223 Deals Announced Worth $46.2 Billion The second quarter of 2010 saw the announcement of 223 mergers and acquisitions in the health care industry. This figure represents a 3% increase over the 217 deals announced in the previous quarter, Q1:10, but a 6%...
Cornerstone’s publicly offered real estate funds are designed and structured to provide individuals and smaller retirement plans with the real estate investment strategy favored by large pension funds and institutional investors. Since 1989 Cornerstone has specialized...